Literature DB >> 2129308

Aspartokinase III repression and lysine analogs utilization for protein synthesis.

M Di Girolamo1, V Busiello, R Coccia, C Foppoli.   

Abstract

The extents of thialysine and selenalysine incorporation into cell proteins were compared in E. coli KL16 and in a mutant able to grow equally well in the presence or in the absence of both lysine analogs. The mutant differs from the parental strain in the repression of aspartokinase III (AKIII), the first enzyme of the lysine biosynthetic pathway. No analog incorporation into proteins was observed in mutant cells grown in the presence of either analog, whereas a marked analog incorporation was observed in the parental strain, where up to 17% and 12% of protein lysine can be substituted by thialysine and selenalysine respectively. In the parental strain grown in media containing either analog at different concentration the extent of analog incorporation into proteins is related to the extent of AKIII repression.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2129308

Source DB:  PubMed          Journal:  Physiol Chem Phys Med NMR        ISSN: 0748-6642


  4 in total

1.  De Novo Guanine Biosynthesis but Not the Riboswitch-Regulated Purine Salvage Pathway Is Required for Staphylococcus aureus Infection In Vivo.

Authors:  Eric M Kofoed; Donghong Yan; Anand K Katakam; Mike Reichelt; Baiwei Lin; Janice Kim; Summer Park; Shailesh V Date; Ian R Monk; Min Xu; Cary D Austin; Till Maurer; Man-Wah Tan
Journal:  J Bacteriol       Date:  2016-06-27       Impact factor: 3.490

2.  An mRNA structure in bacteria that controls gene expression by binding lysine.

Authors:  Narasimhan Sudarsan; J Kenneth Wickiser; Shingo Nakamura; Margaret S Ebert; Ronald R Breaker
Journal:  Genes Dev       Date:  2003-11-01       Impact factor: 11.361

Review 3.  Amino acid recognition and gene regulation by riboswitches.

Authors:  Alexander Serganov; Dinshaw J Patel
Journal:  Biochim Biophys Acta       Date:  2009-07-18

Review 4.  Emerging applications of riboswitches - from antibacterial targets to molecular tools.

Authors:  Piotr Machtel; Kamilla Bąkowska-Żywicka; Marek Żywicki
Journal:  J Appl Genet       Date:  2016-03-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.